<DOC>
	<DOCNO>NCT01405573</DOCNO>
	<brief_summary>The purpose study compare addition sorafenib ( 800 mg/day ) best supportive care best supportive care alone term survival patient hepatocellular carcinoma ( HCC ) impair liver function ( Child B ) .</brief_summary>
	<brief_title>Sorafenib First-line Treatment Advanced B Child Hepatocellular Carcinoma</brief_title>
	<detailed_description>Hepatocellular carcinoma ( HCC ) third cause death cancer world increase incidence . No systemic therapy proven effective patient advance HCC 2007 , result SHARP trial present . In trial , orally active multi-kinase inhibitor sorafenib ( 800 mg/day ) significantly prolong survival compare placebo patient advance HCC good liver function ( Child A ) . The author conclude effect drug population patient impair liver function study .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Sorafenib</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<criteria>Patients diagnosis hepatic cell carcinoma ( HCC ) accord AASLD EASL criterion Age &gt; 18 year Advanced stage disease define HCC eligible locoregional treatment ( ab initio follow progression treatment ) Liver function classify ChildPugh class B ECOG performance status &lt; = 2 Life expectancy least 2 month Adequate contraception fertile male female patient Signed informed consent Prior exposure sorafenib antiangiogenesis drug Concomitant disease contraindicate use sorafenib Gastrointestinal bleeding previous 30 day Altered renal function ( creatinine &gt; 1.5 x ULN ) , haematological function ( platelet count &lt; 60 x 10^9/L , hemoglobin &lt; 9 g/dl ) Serious active infection ( &gt; grade 2 CTCAE version 3.0 ) Congestive heart failure , history congestive heart failure , unstable angina pectoris , myocardial infarct significant valvular heart disease uncontrolled heart arrhythmia Patients unable unwilling participate study Pregnant lactating female Hepatic encephalopathy grade</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Child Pugh B</keyword>
	<keyword>first line</keyword>
</DOC>